Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Creverse, Inc. (096240.KQ)
Seoul, KR
Founded in 1998 and headquartered in Seoul, South Korea, Creverse, Inc. operates as an educational firm with a presence both domestically and globally. This company delivers comprehensive learning solutions, encompassing content for early childhood (kindergarten) and adult education, alongside the management of dedicated assessment facilities. The entity formerly operated under the name CHUNGDAHM Learning, Inc., before officially adopting its current designation, Creverse, Inc., in March 2022.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.66% | -7.07% | -17.41% | -21.23% | -27.67% | -24.78% | -35.21% | -52.33% | -72.78% | -41.59% | -77.20% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
-
Revenue growth Personal Products & Services: +6.6%-2.3% Q3'25: +1.8% (vs Q3'24)
-
EPS growth Personal Products & Services: +19.6%-50.0% Q3'25: +3,218.5% (vs Q3'24)
-
FCF margin FCF growth · Personal Products & Services: +11.7%+7.1% Q3'25: -12.2% (vs Q3'24)
-
EBIT margin Personal Products & Services: +10.5%+5.7% Q3'25: +25.4% (vs Q3'24)
-
ROIC Personal Products & Services: +6.9%+8.9% ★ Q3'25: +64.3% (vs Q3'24)
-
Share dilution Personal Products & Services: +0.0%+0.9% Q3'25: +8.9% (vs Q3'24)
-
Debt / EBITDA Net debt/EBITDA · Personal Products & Services: 0.59×2.82× Q3'25: 0.51× (vs Q3'24)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2024 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
Dec 2030 1 Rev. Ana. 1 EPS Ana. |
Dec 2031 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|
| Revenue |
228.17B
est: 260.50B (-12.4%)
|
150.75B
150.75B – 150.75B
-42.1% YoY
|
154.05B
154.05B – 154.05B
+2.2% YoY
|
173.10B
173.10B – 173.10B
+12.4% YoY
|
179.80B
179.80B – 179.80B
+3.9% YoY
|
213.60B
213.60B – 213.60B
+18.8% YoY
|
260.50B
260.50B – 260.50B
+22.0% YoY
|
| EBITDA |
38.18B
est: 51.35B (-25.6%)
|
29.72B
29.72B – 29.72B
-42.1% YoY
|
30.37B
30.37B – 30.37B
+2.2% YoY
|
34.12B
34.12B – 34.12B
+12.4% YoY
|
35.44B
35.44B – 35.44B
+3.9% YoY
|
42.11B
42.11B – 42.11B
+18.8% YoY
|
51.35B
51.35B – 51.35B
+22.0% YoY
|
| EBIT |
13.00B
est: 23.34B (-44.3%)
|
13.51B
13.51B – 13.51B
-42.1% YoY
|
13.80B
13.80B – 13.80B
+2.2% YoY
|
15.51B
15.51B – 15.51B
+12.4% YoY
|
16.11B
16.11B – 16.11B
+3.9% YoY
|
19.14B
19.14B – 19.14B
+18.8% YoY
|
23.34B
23.34B – 23.34B
+22.0% YoY
|
| Net Income |
7.57B
est: 30.41B (-75.1%)
|
8.56B
8.56B – 8.56B
-71.8% YoY
|
8.90B
8.90B – 8.90B
+3.9% YoY
|
12.16B
12.16B – 12.16B
+36.7% YoY
|
8.40B
8.40B – 8.40B
-30.9% YoY
|
22.12B
22.12B – 22.12B
+163.2% YoY
|
30.41B
30.41B – 30.41B
+37.5% YoY
|
| SGA |
121.11B
est: 117.15B (+3.4%)
|
67.80B
67.80B – 67.80B
-42.1% YoY
|
69.28B
69.28B – 69.28B
+2.2% YoY
|
77.85B
77.85B – 77.85B
+12.4% YoY
|
80.86B
80.86B – 80.86B
+3.9% YoY
|
96.06B
96.06B – 96.06B
+18.8% YoY
|
117.15B
117.15B – 117.15B
+22.0% YoY
|
| EPS |
902.00
est: 3,619.00 (-75.1%)
|
1,019.00
1,019.00 – 1,019.00
-71.8% YoY
|
1,058.50
1,058.50 – 1,058.50
+3.9% YoY
|
1,447.00
1,447.00 – 1,447.00
+36.7% YoY
|
1,000.00
1,000.00 – 1,000.00
-30.9% YoY
|
2,632.00
2,632.00 – 2,632.00
+163.2% YoY
|
3,619.00
3,619.00 – 3,619.00
+37.5% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-05-28 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-05-27 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-05-26 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-05-22 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-05-21 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-05-20 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-05-19 | A- | 4/5 | 1/5 | 5/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-05-18 | A- | 4/5 | 1/5 | 5/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-05-15 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 4/5 | 3/5 |
| 2026-05-14 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 4/5 | 3/5 |
| 2026-05-13 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 4/5 | 3/5 |
| 2026-05-12 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 4/5 | 3/5 |
| 2026-05-11 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 4/5 | 3/5 |
| 2026-05-08 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 4/5 | 3/5 |
| 2026-05-07 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 4/5 | 3/5 |
| 2026-05-06 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 4/5 | 3/5 |
| 2026-05-04 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 4/5 | 3/5 |
| 2026-04-30 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 4/5 | 3/5 |
| 2026-04-29 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 4/5 | 3/5 |
| 2026-04-28 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 4/5 | 3/5 |
| 2026-04-27 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 4/5 | 3/5 |
| 2026-04-24 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 4/5 | 3/5 |
| 2026-04-23 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 4/5 | 3/5 |
| 2026-04-22 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 4/5 | 3/5 |
| 2026-04-21 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 4/5 | 3/5 |
| 2026-04-20 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 4/5 | 3/5 |
| 2026-04-17 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 4/5 | 3/5 |
| 2026-04-16 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 4/5 | 3/5 |
| 2026-04-15 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 4/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive team data is not available for this company yet.
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 096240.KQ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
